Results for tag: "Pristiq"

Pristiq is a prescription medication used to treat major depressive disorder (MDD) and other mental health conditions. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce symptoms of depression. Pristiq is available in both immediate-release and extended-release forms, and is typically taken once daily. The mental disorders drugs market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global mental disorders drugs market is expected to reach over $100 billion by 2025. This growth is driven by increasing prevalence of mental health disorders, rising awareness of mental health issues, and the availability of new treatments. The Pristiq market is a subset of the mental disorders drugs market. It is a relatively new drug, having been approved by the FDA in 2008, and is used to treat MDD and other mental health conditions. Companies in the Pristiq market include Pfizer, Inc., Eli Lilly and Company, and GlaxoSmithKline plc. Show Less Read more